These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5076274)

  • 21. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
    Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
    Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

  • 26. The dependence of the effects of i.cor. administered adenosine and of coronary conductance on the arterial pH, pCO 2 and buffer capacity in dogs.
    Raberger G; Weissel M; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(3):301-10. PubMed ID: 4257118
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man].
    Kochsiek K; Neubaur J
    Arzneimittelforschung; 1972 Feb; 22(2):353-8. PubMed ID: 5067487
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 31. Esters and carbamates of 4-dialkylamino-1,2-diphenyl-3-methyl-2-butanols with coronary dilator activity. Note II.
    Bellasio E; Trani A; Cavalleri B; Sardi A; Caravaggi AM
    Farmaco Sci; 1974 May; 29(5):335-48. PubMed ID: 4838290
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of some vasodilator agents on coronary flow].
    Palazzoadriano M; Raineri A; Battaglia A; Profeta F; Cospite M; Casuccio L
    Boll Soc Ital Cardiol; 1970; 15(5):388-401. PubMed ID: 4145038
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronary vascular and myocardial responses to carotid body stimulation in the dog.
    Ehrhart IC; Parker PE; Weidner WJ; Dabney JM; Scott JB; Haddy FJ
    Am J Physiol; 1975 Sep; 229(3):754-60. PubMed ID: 2017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of selective serotonin administration into different portions of the coronary vascular bed on the retrograde (collateral) coronary blood flow in myocardial ischemia in dogs].
    Azarov VI; Hrabovs'kyĭ LO; Moĭbenko OO
    Fiziol Zh (1994); 1999; 45(1-2):26-34. PubMed ID: 10202633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on the effect of coronary dilators on the coronary blood circulation in man].
    Hilger HH; Behrenbeck DW; Hellwig H; Wagner J
    Arzneimittelforschung; 1970 Mar; 20():441-2. PubMed ID: 5468726
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physiology of the coronary circulation as a basis for evaluation of coronary dilators].
    Lochner W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):127-44. PubMed ID: 4979631
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of magnesium asparaginate on the coronary circulation.
    Görög P; Ezer E; Szporny L
    Arzneimittelforschung; 1966 Nov; 16(11):1488-90. PubMed ID: 6014963
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilator effects of sulfinpyrazone in dogs.
    Thomas M; Gabe IT; Mills CJ
    J Cardiovasc Pharmacol; 1980; 2(6):771-6. PubMed ID: 6160327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.